Browse by author
Lookup NU author(s): Stephen Aldridge, Professor Thomas Lennard, John Williams, Dr Mark Birch
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Vascular endothelial growth factor (VEGF) is a proangiogenic cytokine that is expressed highly in many solid tumours often correlating with a poor prognosis. In this study, we investigated the expression of VEGF and its receptors in bone metastases from primary human breast tumours and further characterised its effects on osteoclasts in vitro. Breast cancer metastases to bone were immunohistochemically stained for VEGF, its receptors VEGFR1 and 2 (vascular endothelial growth factor receptor 1 and 2), demonstrating that breast cancer metastases express VEGF strongly and that surrounding osteoclasts express both VEGFR1 and VEGFR2. RAW 264.7 cells (mouse monocyte cell line) and human peripheral blood mononuclear cells (PBMCs) were cultured with VEGF, RANKL and M-CSF, VEGF and RANKL together induced differentiation of multinucleated, tartrate-resistant acid phophatase (TRAP)-positive cells in similar numbers to M-CSF and RANKL The PBMCs were also able to significantly stimulate resorption of mineralised matrix after treatment with M-CSF with RANKL and VEGF with RANKL. We have shown that VEGF in the presence of RANKL supports PBMC differentiation into osteoclast-like cells, able to resorb substrate. Vascular endothelial growth factor may therefore play a role in physiological bone resorption and in pathological situations. Consequently, VEGF signalling may be a therapeutic target for osteoclast inhibition in conditions such as tumour osteolysis. © 2005 Cancer Research UK.
Author(s): Aldridge, S.E., Lennard, T.W.J., Williams, J., Birch, M.A.
Publication type: Article
Publication status: Published
Journal: British Journal of Cancer
Year: 2005
Volume: 92
Issue: 8
Pages: 1531-1537
Print publication date: 25/04/2005
ISSN (print): 0007-0920
ISSN (electronic): 1532-1827
URL: http://dx.doi.org/10.1038/sj.bjc.6602417
DOI: 10.1038/sj.bjc.6602417
PubMed id: 15812559
Altmetrics provided by Altmetric
